IT8421436A1 - Un plasmide ricombinante, un microorganismo trasformante, un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina così prodotta - Google Patents

Un plasmide ricombinante, un microorganismo trasformante, un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina così prodotta

Info

Publication number
IT8421436A1
IT8421436A1 IT1984A21436A IT2143684A IT8421436A1 IT 8421436 A1 IT8421436 A1 IT 8421436A1 IT 1984A21436 A IT1984A21436 A IT 1984A21436A IT 2143684 A IT2143684 A IT 2143684A IT 8421436 A1 IT8421436 A1 IT 8421436A1
Authority
IT
Italy
Prior art keywords
protein
polydeoxyribonucleotide
segment
producing
produced
Prior art date
Application number
IT1984A21436A
Other languages
English (en)
Other versions
IT8421436A0 (it
IT1175508B (it
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Publication of IT8421436A0 publication Critical patent/IT8421436A0/it
Publication of IT8421436A1 publication Critical patent/IT8421436A1/it
Application granted granted Critical
Publication of IT1175508B publication Critical patent/IT1175508B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
IT21436/84A 1983-06-23 1984-06-15 Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta IT1175508B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8303626A SE8303626D0 (sv) 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced

Publications (3)

Publication Number Publication Date
IT8421436A0 IT8421436A0 (it) 1984-06-15
IT8421436A1 true IT8421436A1 (it) 1985-12-15
IT1175508B IT1175508B (it) 1987-07-01

Family

ID=20351747

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21436/84A IT1175508B (it) 1983-06-23 1984-06-15 Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta

Country Status (5)

Country Link
EP (1) EP0130166A1 (it)
JP (1) JPS6019493A (it)
GB (1) GB2142033A (it)
IT (1) IT1175508B (it)
SE (1) SE8303626D0 (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
GB8522977D0 (en) * 1985-09-17 1985-10-23 Fujisawa Pharmaceutical Co Production of insulin-like growth factor 1
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
GB8507833D0 (en) * 1985-03-26 1985-05-01 Biogen Nv Production of human somatomedin c
EP0219814B1 (en) * 1985-10-21 1991-09-11 Fujisawa Pharmaceutical Co., Ltd. Process for production of isulin-like growth factor i and plasmid for production thereof
JPH0817708B2 (ja) * 1986-10-09 1996-02-28 藤沢薬品工業株式会社 Ｍｅｔ−インスリン様成長因子Ｉの発現ベクター
JPH03505966A (ja) * 1988-07-14 1991-12-26 ベイラー カレッジ オブ メディシン 生物高分子の固相組立及び再構築方法
ATE143696T1 (de) * 1989-02-28 1996-10-15 Canon Kk Partiell doppelsträngiges oligonukleotid und verfahren zu seiner bildung
JP2682738B2 (ja) * 1989-06-09 1997-11-26 グロペップ プロプライエタリー リミテッド 成長ホルモン融合蛋白質
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
AU3812993A (en) * 1992-03-24 1993-10-21 Synergen, Inc. Refolding and purification of insulin-like growth factor I
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE19940750A1 (de) 1998-08-28 2000-06-21 Febit Ferrarius Biotech Gmbh Träger für Analytbestimmungsverfahren und Verfahren zur Herstellung des Trägers
ATE334197T1 (de) 1999-02-19 2006-08-15 Febit Biotech Gmbh Verfahren zur herstellung von polymeren
AU2006242129A1 (en) 2005-05-02 2006-11-09 Genzyme Corporation Gene therapy for spinal cord disorders
PT3520823T (pt) 2005-05-02 2021-09-16 Genzyme Corp Terapia genética para distúrbios neurometabólicos
AR059089A1 (es) 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
AR059088A1 (es) * 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una proteina para esclerosis lateral amiotrofica
MX361816B (es) 2006-02-09 2018-12-17 Genzyme Corp Suministro intraventricular lento.
CN101460621B (zh) 2006-06-07 2016-01-27 建新公司 肌萎缩性侧索硬化和其他脊髓失调症的基因治疗
DK2066791T3 (da) 2006-10-03 2012-10-15 Genzyme Corp Genterapi for amyotrofisk lateralsklerose og andre rygmarvssygdomme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201918A (en) * 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone

Also Published As

Publication number Publication date
JPS6019493A (ja) 1985-01-31
IT8421436A0 (it) 1984-06-15
IT1175508B (it) 1987-07-01
EP0130166A1 (en) 1985-01-02
GB2142033A (en) 1985-01-09
SE8303626D0 (sv) 1983-06-23
GB8416007D0 (en) 1984-07-25

Similar Documents

Publication Publication Date Title
IT8421436A0 (it) Proteina cosi' prodotta. un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la
AU3228789A (en) Biologically active proteins
IT9048315A0 (it) Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
ATA257190A (de) Virales polypeptid
GR81040B (en) Highly purified protein, production and use thereof
DE3882593D1 (de) Polypeptid und dessen herstellung.
SE8204810D0 (sv) Recombinant dna molecule, transformed microorganism and process for producing protein a
NZ212155A (en) Purification of protein/peptide material by electroseparation
FI970258L (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
SE9501285L (sv) Förfarande för framställning av biologiskt aktiva proteiner
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
EP0816510A4 (en) PROCESS FOR PRODUCING BIOLOGICALLY ACTIVE FUSED PROTEINS
NO854405L (no) Fremgangsmaate for fremstilling av et antibiotisk aktivt polypeptid.
GB9104596D0 (en) Production of recombinant proteins
AU1704988A (en) Peptide production by protein engineering
AU557783B2 (en) Biologically active peptides
IT1230483B (it) Procedimento per la produzione di una proteina endotossica, gene strutturale impiegato e composizioni insetticide comprendenti detta proteina
FI944997A7 (fi) Parannettu rekombinantti-proteiinien tuotanto
IT8719551A0 (it) Plasmidi ricombinanti utili perl'espressione in bacillus di proteine eterologhe.
DE3481420D1 (de) Physiologisch aktives proteinmaterial.
FI955463A7 (fi) Menetelmä biologisesti aktiivisten polypeptidien tuottamiseksi rekombi nanttitekniikalla
FR2650908B3 (fr) Chaise publicitaire
DE3869939D1 (de) Biologisch wirksame peptide.
NO892716L (no) Fremgangsmaate for fremstilling av proteiner.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970628